October 20, 2026
ALZAI Health Corp.
ISIN: CA02262P1036
ALZAI Health Corp. Posted for Trading on the OTCQB Venture Market
TORONTO, ONTARIO – October 20, 2026 – ALZAI Health Corp. (TSXV: ALZI) (OTCQB: ALZIF) (FRA: H2F) (“ALZAI” or the “Company”), a healthcare technology company developing artificial intelligence-driven disease risk identification...
Read more >>Alzai Health Corp. Announces Marketing Services Agreement
Toronto, Ontario – August 17, 2026 - Alzai Health Corp. (TSXV: ALZI) (the "Company" or "ALZAI") announces that it has entered into a services agreement dated August 12, 2026 (the "Services Agreement") with Euro Digital Media Ltd. ("Euro Digital") (address: 71-75 Shelton Street, Covent Garden, London, UK WC2H 9JQ) pursuant...
Read more >ALZAI and Linus Health explore AI-driven collaborations aimed at early identification of Alzheimer’s disease risk and cognitive impairment
TORONTO, ONTARIO AND BOSTON, MASSACHUSETTS – August 11, 2026 – ALZAI Health Corp. (TSXV: ALZI) is pleased to announce that it has entered into a Memorandum of Understanding (MOU) with Linus Health, an AI-driven brain health company focused on early detection and proactive intervention. The companies intend to explore opportunities...
Read more >ALZAI Health Corp. Secures Exclusive Global License for AI-Driven Liver Disease Risk Identification Technology
TORONTO, ONTARIO – July 20, 2026 – ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce that it has entered into an exclusive worldwide license agreement (the "Agreement") with MOR Research Applications Ltd. ("MOR"), the technology transfer company of Clalit Health Services and Yeda Research, the...
Read more >ALZAI Health Corp. Signs Strategic U.S. Commercialization Agreement With Centauri Health Solutions to Advance AI-Driven Alzheimer’s Risk Identification
TORONTO, ONTARIO – July 2, 2026 - ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce that it has entered into a strategic teaming agreement (the "Agreement") with Centauri Health Solutions ("Centauri"), a leading U.S. healthcare technology company serving 60 million members through advanced mission-critical technology,...
Read more >